Amide
Bridging the synthesis gap
Amide was founded in 2023, is headquartered in Cambridge, United States, lists 11–50 employees, and has $16.5M in recorded funding across 3 rounds.
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2023
- Business Model
- B2B
- Website
- amidetech.com
- Total Funding
- $16.5M
- Last Round
- $7.5M Extension RoundJul 2023
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.
About
Amide Technologies is a biotech startup offering on-demand complex peptide manufacturing at unprecedented speed, bridging the gap between traditional solid-phase peptide synthesis and biological expression. Founded on technology developed at MIT, Amide uses its proprietary Automated Fast-Flow Peptide Synthesis (AFPS) platform to synthesize peptides that other vendors cannot, including those with unnatural amino acids and artificial protein backbones. The company accepts orders other vendors refuse and ships urgent orders in less than a week, enabling rapid design-build-test cycles for biopharma customers. Amide raised $16.5M to expand its platform and expedite frontier drug discovery programs.
Summary
Amide is a Biotech company based in Cambridge, United States, founded in 2023. It lists 11–50 employees. It has raised $16.5M in total across 3 rounds, most recently a $7.5M Extension Round in Jul 2023. Investors include Engine Ventures, Biological Engineering Ventures and Khosla Ventures.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jul 2023
Sign up to see all 3 events
Funding: Extension Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Enveda reads and translates nature’s hidden chemistry to accelerate the discovery of better medic...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/amide"><img src="https://indexed.vc/api/badge/company/amide" alt="Amide on Indexed.vc" width="260" height="76" /></a>